Stenslik, M. ., Potts, L. ., Sonne, J. ., Cass, W. ., Turchan-Cholewo, J. ., Pomerleau, F. ., … Bradley, L. . (2015). Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson’s disease. Journal of Neuroscience Methods, 251, 120-9. https://doi.org/10.1016/j.jneumeth.2015.05.006 (Original work published 2015)

Fuqua, J. ., Littrell, O. ., Lundblad, M. ., Turchan-Cholewo, J. ., Abdelmoti, L. ., Galperin, E. ., … Gerhardt, G. . (2014). Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides, 54, 1-8. https://doi.org/10.1016/j.peptides.2013.12.007

Littrell, O. ., Fuqua, J. ., Richardson, A. ., Turchan-Cholewo, J. ., Hascup, E. ., Huettl, P. ., … Gerhardt, G. . (2013). A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function. Neuropeptides, 47(1), 43-9. https://doi.org/10.1016/j.npep.2012.08.004

Kelps, K. ., Turchan-Cholewo, J. ., Hascup, E. ., Taylor, T. ., Gash, D. ., Gerhardt, G. ., & Bradley, L. . (2011). Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence. Neuropeptides, 45(3), 213-8. https://doi.org/10.1016/j.npep.2011.03.003

Bradley, L. ., Fuqua, J. ., Richardson, A. ., Turchan-Cholewo, J. ., Ai, Y. ., Kelps, K. ., … Gerhardt, G. . (2010). Dopamine neuron stimulating actions of a GDNF propeptide. PloS One, 5(3), e9752. https://doi.org/10.1371/journal.pone.0009752 (Original work published 2010)

Stenslik, M. ., Evans, A. ., Pomerleau, F. ., Weeks, R. ., Huettl, P. ., Foreman, E. ., … Bradley, L. . (2018). Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques. Journal of Neuroscience Methods, 303, 30-40. https://doi.org/10.1016/j.jneumeth.2018.03.006 (Original work published 2018)

Grondin, R. ., Littrell, O. ., Zhang, Z. ., Ai, Y. ., Huettl, P. ., Pomerleau, F. ., … Gerhardt, G. . (2019). GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology, 147, 28-36. https://doi.org/10.1016/j.neuropharm.2018.05.014 (Original work published 2019)

Sompol, P. ., Furman, J. ., Pleiss, M. ., Kraner, S. ., Artiushin, I. ., , … Norris, C. . (2017). Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(25), 6132-6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017 (Original work published 2017)

Thomas, T. ., Beitchman, J. ., Pomerleau, F. ., Noel, T. ., Jungsuwadee, P. ., Butterfield, D. ., … Gerhardt, G. . (2017). Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Research, 1672, 10-17. https://doi.org/10.1016/j.brainres.2017.07.003 (Original work published 2017)

Gash, D. ., Gerhardt, G. ., Bradley, L. ., Wagner, R. ., & Slevin, J. . (2020). GDNF clinical trials for Parkinson’s disease: a critical human dimension. Cell and Tissue Research, 382(1), 65-70. https://doi.org/10.1007/s00441-020-03269-8